Preparation of deacetyl-, lyso-, and deacetyl-lyso-GM3 by selective alkaline hydrolysis of GM3 ganglioside

Journal of Lipid Research

Volumn 42, Issue 8, 2001, Pages 1318-1324

  Valiente, Oscar ^a   Mauri, Laura ^b   Casellato, Riccardo ^b   Fernandez, Luis E ^a   Sonnino, Sandro ^b  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

ESI MS; tert butoxide; TLC staining; Tritium

Indexed keywords

GANGLIOSIDE GM3;

ARTICLE; CHEMICAL STRUCTURE; COLUMN CHROMATOGRAPHY; LIPOGENESIS; MASS SPECTROMETRY; PRIORITY JOURNAL; REACTION TIME; TEMPERATURE DEPENDENCE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORIMETRY; G(M3) GANGLIOSIDE; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; HYDROXIDES; KINETICS; N-ACETYLNEURAMINIC ACID; NEURAMINIC ACIDS; POTASSIUM COMPOUNDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPHINGOSINE; TRITIUM;

EID: 0034885062     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gangliosides as receptors for bacterial toxins and sendai virus
2. Animal glycosphingolipids as membrane attachment sites for bacteria
3. Biosynthesis and functions of gangliosides: Recent advances
4. Gangliosides of T lymphocytes: Evidences for a role in T-cell activation
5. Immunosuppressive activity of chemically synthesized gangliosides
6. Immunosuppression by human gangliosides. I. Relationship of carbohydrate structure to the inhibition of T cell responses
7. Immunosuppressive activity of glycosphingolipids. Influence of serum factors on ganglioside inhibition of IL-4-dependent cell proliferation
8. Glycolipids in human lung carcinoma of histologically different types
9. Gangliosides of human melanoma
10. Gangliosides expressed in human breast cancer
11. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography
12. Aberrant expression of gangliosides in human renal cell carcinomas
13. Changes in glycolipids in human renal cell carcinoma and their clinical significance
14. Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody and GM3 lactone as a possible immunogen: Requirements for tumor-associated antigen and immunogen
15. An IgG3 monoclonal antibody established after immunization with GM3 lactone: Immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo
16. Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen in human cancers
17. A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma
18. Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP)
19. GD3 vaccines for melanoma: Superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines
20. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor
21. Preparation of lysohematoside (neuraminyl-galactosyl-glucosylsphingosine) from hematoside of equine erythrocyte, and its chemical and hemolytic properties
22. Preparation of GM1 ganglioside molecular species, having homogeneous fatty acid and long chain base moieties
23. Synthesis of lysogangliosides
24. 4-long chain bases) by a one-pot reaction
25. Improved preparation method for lysogangliosides
26. 2-LactosylCer), and related compounds
27. Preparation of various lysogangliosides including lyso-fucosyl GM1 and delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometric analysis
28. A procedure for the preparation of GM3 ganglioside from GM1-lactone
29. Specific tritium labeling of gangliosides at the 3-position of sphingosines
30. High performance liquid chromatography preparation of the molecular species of GM1 and GD1a gangliosides with homogeneous long chain base composition
31. Evaluation of the efficiency of the assay procedure for the determination of gangliosides in human serum
32. Preparation of radiolabeled gangliosides
33. Quantitative estimation of sialic acid. II. A colorimetric resorcinol-hydrochloric acid method
34. Use of butyl acetate in determination of sialic acid
35. Filter-paper partition chromatography of sugars. I. General description and application to the qualitative analysis of sugar in apple juice egg white and fetal blood of sheep
36. Characterization of sialic acids
37. Tissue receptor for cholera exotoxin: Structural requirements of GM1 ganglioside in toxin binding and inactivation
38. Isolation of cholera toxin by affinity chromatography on porous silica beads with covalently coupled ganglioside GM1
39. 14C labeling of sialic acid and N-acetylhexosamine residues of glycosphingolipids after hydrazinolysis
40. 3Neu5AcLacCer) in aqueous solutions